3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Mycoses
2
Leukemia
2
Triple Negative Breast Neoplasms
1
Prostatic Neoplasms
1
Ovarian Neoplasms
1
Neutropenia
1
Neoplasms
1
Neoplasm Metastasis
1
Myelodysplastic-Myeloproliferative Diseases
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma
1
Leukemia, Myelomonocytic, Acute
1
Leukemia, Myeloid, Acute
1
Leukemia, Monocytic, Acute
1
Invasive Fungal Infections
1
Infections
1
Hematologic Neoplasms
1
Endometriosis
1
Carcinoma, Non-Small-Cell Lung
1
B-cell Malignancies
1
Advanced Solid Tumors
1
Interventions
Brentuximab Vedotin
13
fludarabine
8
Cyclophosphamide
8
Rituximab
6
ruxolitinib
5
fludarabine phosphate
5
Melphalan
5
Lenalidomide
5
ponatinib
4
Dexamethasone
4
Busulfan
4
Bortezomib
4
nilotinib
3
Whole-Body Irradiation
3
Vincristine
3
Prednisone
3
Mycophenolic Acid
3
Imatinib Mesylate
3
Doxorubicin
3
Bendamustine Hydrochloride
3
Alemtuzumab
3
vosaroxin
2
pomalidomide
2
Tacrolimus
2
Sugars
2
Stem Cell Transplantation
2
Sirolimus
2
Ondansetron
2
Leukapheresis
2
Granulocyte Colony-Stimulating Factor
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Hematologic Diseases
×
Fluconazole
×
Clear all
No trials found.